Free Trial

Denali Therapeutics (DNLI) Institutional Ownership

Denali Therapeutics logo
$16.64 +0.58 (+3.58%)
As of 12:12 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Denali Therapeutics (NASDAQ:DNLI)

Current
Institutional Ownership
Percentage
92.92%
Number of
Institutional Buyers
(last 12 months)
126
Total
Institutional Inflows
(last 12 months)
$644.07M
Number of
Institutional Sellers
(last 12 months)
75
Total
Institutional Outflows
(last 12 months)
$241.96M
Get DNLI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Denali Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

DNLI Institutional Buying and Selling by Quarter

Denali Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/1/2025New York State Common Retirement Fund70,240$955K0.0%-51.5%0.048%
4/30/2025 Alps Advisors Inc.111,375$1.51M0.0%-4.3%0.077%
4/30/2025 DekaBank Deutsche Girozentrale64,210$935K0.0%+7.4%0.044%
4/30/2025 China Universal Asset Management Co. Ltd.29,128$396K0.0%-4.6%0.020%
4/29/2025 Envestnet Asset Management Inc.31,430$427K0.0%-16.5%0.022%
4/29/2025 Bank of New York Mellon Corp1,103,892$15.01M0.0%-11.2%0.760%
4/29/2025 VELA Investment Management LLC27,771$378K0.1%+77.6%0.019%
4/28/2025 Principal Financial Group Inc.1,081,578$14.70M0.0%-4.4%0.745%
4/28/2025 Teacher Retirement System of Texas34,857$474K0.0%-8.7%0.024%
4/18/2025 Clarius Group LLC368,995$5.02M0.3%-10.0%0.254%
4/15/2025 SG Americas Securities LLC48,365$658K0.0%+339.6%0.033%
4/10/2025 Breakwater Capital Group15,015$204K0.0%N/A0.010%
4/7/2025 GAMMA Investing LLC7,953$108K0.0%+253.8%0.005%
3/18/2025California State Teachers Retirement System120,174$2.45M0.0%-0.8%0.083%
2/25/2025Polar Asset Management Partners Inc.551,092$11.23M0.1%+1,240.9%0.383%
2/19/2025 GF Fund Management CO. LTD.3,022$62K0.0%N/A0.002%
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC3,582,874$73.02M0.0%-4.4%2.489%
2/17/2025Woodline Partners LP100,000$2.04M0.0%N/A0.069%
2/17/2025Squarepoint Ops LLC48,619$991K0.0%+44.2%0.034%
2/17/2025Twinbeech Capital LP254,586$5.19M0.1%N/A0.177%
2/17/2025Two Sigma Advisers LP15,100$308K0.0%N/A0.010%
2/17/2025Two Sigma Investments LP179,884$3.67M0.0%+80.8%0.125%
2/17/2025Stempoint Capital LP584,328$11.91M3.0%+107.2%0.406%
2/17/2025Rafferty Asset Management LLC141,310$2.88M0.0%+20.1%0.098%
2/17/2025Point72 Asset Management L.P.548,739$11.18M0.0%+64.5%0.381%
2/17/2025Point72 Hong Kong Ltd3,175$65K0.0%N/A0.002%
2/17/2025Polar Asset Management Partners Inc.551,092$11.23M0.2%+1,240.9%0.383%
2/17/2025ProShare Advisors LLC41,825$852K0.0%+30.9%0.029%
2/17/2025Man Group plc22,435$457K0.0%-26.3%0.016%
2/17/2025Nuveen Asset Management LLC355,057$7.24M0.0%-50.4%0.247%
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 21,039$429K0.0%-31.6%0.015%
2/17/2025Millennium Management LLC404,224$8.24M0.0%+571.8%0.281%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.85,075$1.73M0.0%+4.2%0.059%
2/17/2025Janus Henderson Group PLC60,028$1.23M0.0%+15.2%0.042%
2/17/2025Graham Capital Management L.P.20,706$422K0.0%+76.0%0.014%
2/17/2025Fred Alger Management LLC91,807$1.87M0.0%-24.3%0.064%
2/17/2025Deutsche Bank AG277,853$5.66M0.0%+15.8%0.193%
2/17/2025Crestline Management LP4,310,732$87.85M2.9%-3.4%2.995%
2/17/2025Brevan Howard Capital Management LP17,917$365K0.0%+60.5%0.012%
2/17/2025Balyasny Asset Management L.P.416,074$8.48M0.0%+822.4%0.289%
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
2/17/2025Bayesian Capital Management LP18,820$384K0.0%+135.3%0.013%
2/17/2025Bank of America Corp DE270,333$5.51M0.0%-22.4%0.188%
2/17/2025BNP Paribas Financial Markets15,943$325K0.0%-42.3%0.011%
2/17/2025Ameriprise Financial Inc.16,743$341K0.0%+126.3%0.012%
2/17/2025Algert Global LLC39,015$795K0.0%-19.8%0.027%
2/17/2025AXA S.A.293,755$5.99M0.0%-14.8%0.204%
2/14/2025Jane Street Group LLC229,165$4.67M0.0%-37.6%0.159%
2/14/2025Northern Trust Corp1,201,518$24.49M0.0%+10.7%0.835%
2/14/2025The Manufacturers Life Insurance Company 208,521$4.25M0.0%+0.8%0.145%
2/14/2025Aquatic Capital Management LLC15,694$320K0.0%N/A0.011%
2/14/2025Susquehanna Fundamental Investments LLC192,563$3.92M0.1%N/A0.134%
2/14/2025Virtus ETF Advisers LLC3,029$62K0.0%-27.3%0.002%
2/14/2025Voya Investment Management LLC54,813$1.12M0.0%-5.2%0.038%
2/14/2025Price T Rowe Associates Inc. MD3,058,615$62.34M0.0%+6.6%2.125%
2/14/2025Dark Forest Capital Management LP12,888$263K0.0%N/A0.009%
2/14/2025Diadema Partners LP60,000$1.22M0.5%N/A0.042%
2/14/2025Hsbc Holdings PLC33,390$680K0.0%+24.2%0.023%
2/14/2025Tower Research Capital LLC TRC 11,288$230K0.0%+2,519.0%0.008%
2/14/2025MetLife Investment Management LLC76,050$1.55M0.0%+5.9%0.053%
2/14/2025Capital Research Global Investors5,477,211$111.63M0.0%-30.7%3.806%
2/14/2025Dimensional Fund Advisors LP1,855,036$37.81M0.0%+19.0%1.289%
2/14/2025First Trust Advisors LP65,442$1.33M0.0%+260.9%0.045%
2/13/2025Marshall Wace LLP1,788,737$36.45M0.0%-9.1%1.243%
2/13/2025Guggenheim Capital LLC48,131$981K0.0%+133.5%0.033%
2/13/2025Walleye Capital LLC24,820$506K0.0%N/A0.017%
2/13/2025XTX Topco Ltd16,087$328K0.0%N/A0.011%
2/13/2025Barclays PLC278,067$5.67M0.0%+8.7%0.193%
2/13/2025Sterling Capital Management LLC1,773$36K0.0%+589.9%0.001%
2/13/2025Raymond James Financial Inc.26,143$533K0.0%N/A0.018%
2/13/2025Legal & General Group Plc149,513$3.05M0.0%-4.2%0.104%
2/13/2025Invesco Ltd.121,478$2.48M0.0%-41.1%0.084%
2/13/2025ADAR1 Capital Management LLC44,826$914K0.2%-56.0%0.031%
2/13/2025FMR LLC8,019,746$163.44M0.0%+2.4%5.572%
2/13/2025 Envestnet Asset Management Inc.37,622$767K0.0%+34.5%0.026%
2/13/2025Wells Fargo & Company MN88,933$1.81M0.0%-5.1%0.062%
2/12/2025Cinctive Capital Management LP130,445$2.66M0.1%-12.5%0.091%
2/12/2025Bryce Point Capital LLC20,550$419K0.1%N/A0.014%
2/12/2025Groupama Asset Managment110,207$2.23M0.0%+41.2%0.077%
2/12/2025Trexquant Investment LP60,656$1.24M0.0%+147.2%0.042%
2/12/2025Geode Capital Management LLC2,935,283$59.84M0.0%-0.7%2.040%
2/12/2025Franklin Resources Inc.74,862$1.53M0.0%-6.5%0.052%
2/12/2025Alliancebernstein L.P.3,315,642$67.57M0.0%+8.8%2.304%
2/12/2025Pier 88 Investment Partners LLC45,410$925K0.2%-23.3%0.032%
2/12/2025Wellington Management Group LLP9,847,951$200.70M0.0%-8.2%6.782%
2/12/2025Schroder Investment Management Group247,800$5.02M0.0%+94.6%0.172%
2/12/2025Pictet Asset Management Holding SA19,356$394K0.0%+17.0%0.013%
2/12/2025Norges Bank1,065,608$21.72M0.0%N/A0.740%
2/12/2025BIT Capital GmbH21,011$428K0.0%-29.4%0.015%
2/12/2025JPMorgan Chase & Co.222,983$4.54M0.0%-5.3%0.155%
2/12/2025Artisan Partners Limited Partnership1,054,523$21.49M0.0%-3.3%0.733%
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
2/11/2025Pier Capital LLC332,319$6.77M1.0%+97.7%0.231%
2/11/2025Segall Bryant & Hamill LLC289,075$5.89M0.1%N/A0.201%
2/11/2025Prudential Financial Inc.110,593$2.25M0.0%-5.8%0.077%
2/11/2025Corebridge Financial Inc.61,800$1.26M0.0%-7.0%0.043%
2/11/2025Vanguard Group Inc.12,021,230$244.99M0.0%+7.6%8.353%
2/11/2025Fox Run Management L.L.C.38,668$788K0.1%N/A0.027%
2/11/2025KLP Kapitalforvaltning AS26,100$532K0.0%N/A0.018%
2/11/2025Sei Investments Co.24,047$490K0.0%-8.5%0.017%
2/11/2025American Century Companies Inc.480,529$9.79M0.0%+6.5%0.334%
2/11/2025Yiheng Capital Management L.P.700,098$14.27M0.5%+16.7%0.486%
(Data available from 1/1/2016 forward)

DNLI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of DNLI shares?

During the previous two years, 218 institutional investors and hedge funds held shares of Denali Therapeutics. The most heavily invested institutionals were Baillie Gifford & Co. ($250.96M), Vanguard Group Inc. ($244.99M), Wellington Management Group LLP ($200.70M), FMR LLC ($163.44M), Temasek Holdings Private Ltd ($156.02M), State Street Corp ($123.86M), and Capital Research Global Investors ($111.63M).Learn more on DNLI's institutional investors.

What percentage of Denali Therapeutics stock is owned by institutional investors?

92.92% of Denali Therapeutics stock is owned by institutional investors. Learn more on DNLI's institutional investor holdings.

Which institutional investors have been buying Denali Therapeutics stock?

Of the 182 institutional investors that purchased Denali Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($7.78M), Capital Research Global Investors ($3.54M), Norges Bank ($2.22M), Vanguard Group Inc. ($1.57M), UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ($1.45M), Point72 Asset Management L.P. ($1.27M), and Wellington Management Group LLP ($1.23M).

How much institutional buying is happening at Denali Therapeutics?

Institutional investors have bought a total of 35,748,019 shares in the last 24 months. This purchase volume represents approximately $861.30M in transactions.

Which Denali Therapeutics major shareholders have been selling company stock?

Of the 102 institutional investors that sold Denali Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Baillie Gifford & Co. ($3.04M), ARCH Venture Management LLC ($2.98M), Capital Research Global Investors ($2.43M), Barclays PLC ($995.93K), Price T Rowe Associates Inc. MD ($979.99K), Wellington Management Group LLP ($893.74K), and Point72 Asset Management L.P. ($719.62K).

How much institutional selling is happening at Denali Therapeutics?

Institutional investors have sold a total of 18,000,515 shares in the last 24 months. This volume of shares sold represents approximately $424.89M in transactions.



This page (NASDAQ:DNLI) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners